Michael R Hayden insider trades

Open-market stock purchases and sales by Michael R Hayden, Director at Ionis Pharmaceuticals Inc, from SEC Form 4 filings since Nov 4, 2014.

Track record: 67% of 9 scored buys are up 5% or more since purchase, averaging +38%.

Recent trades

DateStockTradeValue
Jul 31, 2026IONS Ionis Pharmaceuticals IncBought$258K
Jul 30, 2026IONS Ionis Pharmaceuticals IncBought$801K
Jul 1, 2026IONS Ionis Pharmaceuticals IncBought (not open market)—
Jul 1, 2026IONS Ionis Pharmaceuticals IncBought (not open market)—
Jun 11, 2026ABCL AbCellera Biologics IncBought (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—

Companies traded

  • IONS Ionis Pharmaceuticals Inc: 4 buys, last Jul 31, 2026
  • ABCL AbCellera Biologics Inc: 3 buys, 1 sale, last Jun 11, 2026
  • ETNB 89bio, Inc: 5 buys, last Oct 30, 2025
  • XENE Xenon Pharmaceuticals Inc: 1 buy, last Jun 3, 2021
  • AUPH Aurinia Pharmaceuticals Inc: other filings, last Jan 29, 2021

Get free alerts when Michael R Hayden files a new trade →